F. D. Costanzo

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

G. Bepler, G. Scagliotti, M. Rinaldi, 2003, Oncogene.

Rapsody: randomized prospective phase II trial of two schedules of sorafenib daily and interferon-α 2A (IFN) in metastatic renal cell carcinoma (MRCC). GOIRC study 0681

C. Porta, C. Boni, A. Santoro, 2007 .

Phase I II R andomized T rial C omparing T hree P latinum-Based Doublets i n A dvanced N on-Small-Cell L ung C ancer

G. Scagliotti, C. Gridelli, M. Rinaldi, 2002 .

The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results

M. Cazzaniga, E. Rulli, P. Pronzato, 2008 .

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)

R. Labianca, E. Matano, C. Boni, 2012, British Journal of Cancer.

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.

W. Scheithauer, F. di Costanzo, M. Palmer, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.

F. di Costanzo, F. Mazzoni, D. Amoroso, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer in elderly women: a different reality? Results from the NORA study.

F. di Costanzo, I. Floriani, A. de Matteis, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.

A. Rossi, C. Gridelli, F. de Marinis, 1997, European journal of cancer.

Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study

F. di Costanzo, I. Floriani, A. de Matteis, 2010, International journal of breast cancer.

Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study

F. di Costanzo, A. Peri, N. Pimpinelli, 2019, Journal of Endocrinological Investigation.